SUBJECT-4225.dossier · person · status: active
PV
subject of file

Patrick Vallance

UK Science Minister addressing Palantir contracts
Tracked because UK Science Minister addressing Palantir contracts · 6 documented connections
Facts on record2
Connections mapped6
Sources cited10
✦ Thin coverage gap +8 connected to 6 entities · only 2 facts on record · flagged for follow-up research
Evidence: 2S
Stated vs Revealed
No documented contradictions on file.
PATTERN instrument → [oversight] → person 21× PATTERN person → [oversight] → instrument 21× PATTERN person → [affiliation] → instrument → [oversight] → person 16× PATTERN person → [oversight] → instrument → [affiliation] → person 16× PATTERN institution → [oversight] → person → [oversight] → instru... 12×
TIMELINE Role Overlap Visualizer →
Connection Map
Key Connections
→ Merck KGaA company
former professional role
Before becoming Chief Scientific Adviser, Vallance was President of Research and Development at Merck KGaA (the German pharmaceutical company), where he worked from 2012 to 2017.
Facts (2)
Data Freshness
Ageing Last update: 159d ago · Avg age: 1554d
Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing
✓ Verified Findings (1)
Independently re-checked: a second model read the source artifact and confirmed it supports the extracted claim.
✓ verified Partially Corroborated Patrick Vallance filed filing with the SEC on 2017-02-03. Accession number: N/A.
Raw Filing Records (1) — unsourced metadata
Pending Review Search scope note: No fec donations found for "Patrick Vallance" in automated database search as of 2026-04-13. This reflects search coverage limits, not confirmed absence from public record.
Added: 13 Apr 2026 UNVERIFIED Research: Patrick Vallance — FEC donations (no results)
All Connections (6)
→ UK Home Office institution
former employment/role secondary since 2018
Patrick Vallance served as the UK Government Chief Scientific Adviser, which involved advising the Home Office on scientific matters, particularly during the COVID-19 pandemic and border policy issues.
→ NHS England institution
former advisory role secondary since 2018
As the UK Government Chief Scientific Adviser (2018-2023), Vallance worked closely with NHS England on health policy and scientific strategy, including during the pandemic response.
→ UK Ministry of Defence institution
former advisory role secondary since 2018
As Government Chief Scientific Adviser, Vallance provided scientific advice to the Ministry of Defence on national security and defense technology matters.
→ Merck KGaA company
former professional role primary since 2012
Before becoming Chief Scientific Adviser, Vallance was President of Research and Development at Merck KGaA (the German pharmaceutical company), where he worked from 2012 to 2017.
→ NHS Digital institution
oversight inferential since 2019
During his tenure as Chief Scientific Adviser, Vallance oversaw scientific aspects of NHS data initiatives, including digital health records and data platforms linked to NHS Digital.
oversight inferential since 2021
Vallance was involved in government health data strategy, which included oversight considerations for NHS England's Federated Data Platform, a system using Palantir's technology.
Sources (10)
2026-05-10 UNVERIFIED SEARCH_ERROR: Patrick Vallance not found in fec claim_flag Processed 📜 Receipt
2026 UNVERIFIED Research: Patrick Vallance — Parliamentary records (no results) parliamentary_record Processed 📜 Receipt
2026 UNVERIFIED Research: Patrick Vallance — Court records (no results) court_document Processed 📜 Receipt
2026 UNVERIFIED Research: Patrick Vallance — Lobbying disclosures (no results) government_disclosure Processed 📜 Receipt
2026 UNVERIFIED Research: Patrick Vallance — FEC donations (no results) fec_record Processed 📜 Receipt